-
Mashup Score: 191The Riddle of Luigi Mangione - 29 day(s) ago
My interactions with the alleged CEO assassin
Source: www.gurwinder.blogCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Dr. Amy Cummings receives award to advance lung cancer research - 1 month(s) ago
The two-year, $500,000 grant supports Cummings’ efforts to advance clinical research and improve outcomes for individuals diagnosed with RET-positive lung cancer.
Source: www.uclahealth.orgCategories: General Medicine News, Hem/OncsTweet-
Congrats to Amy, and thanks go out to @LUNGevity! #lcsm https://t.co/L0H4f5Zyqq cc @RetRenegades @UCLAHealthJCCC https://t.co/zNwU2Rnu3J
-
-
Mashup Score: 28P23. NAUTIKA1: Phase II Study of Neoadjuvant Atezolizumab (atezo)… - 1 month(s) ago
At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions…
Source: www.aats.orgCategories: General Medicine News, Hem/OncsTweet-
An updated report from the MISSILE study team clarifies that preop SBRT is unlikely to help pts with stage I NSCLC undergoing lung resection. Whether preop SBRT + Atezo can help remains the topic of the NAUTIKA-1 study. https://t.co/Ftiw2LlsgD https://t.co/AUG4FQHjlP
-
-
Mashup Score: 10
The use of stereotactic radiotherapy is more prevalent among patients facing barriers to care. Further research is needed to clarify the role of this treatment modality in early-stage lung cancer.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
A well-conducted study by @huroqu90 leveraging the NCDB sheds light on factors associated with higher utilization of SBRT instead of surgery for stage I NSCLC. #radonc https://t.co/DePvLDA5NB cc @SaraSakowitz https://t.co/h60Hto5Fgz
-
-
Mashup Score: 114Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial - 1 month(s) ago
Stereotactic body radiotherapy (SBRT) is increasingly used to treat early-stage non-small cell lung cancer (NSCLC) in medically inoperable patients. Excellent rates of local control (87 %-95 %) and overall survival (65–76 %) have been reported, and toxicity rates are generally low [1–4].
Source: www.thegreenjournal.comCategories: General Medicine News, Hem/OncsTweet-
The largest randomized phase III trial evaluating lung SBRT publishes a secondary analysis of 30 patients with ultra central tumors. #radonc https://t.co/VTtynHgMlf https://t.co/l43uX0yLp7
-
-
Mashup Score: 1
The purpose of this study was to determine the optimal extent of lymph node dissection required in patients with small (≤3 cm) radiologically ground-glass opacity–dominant, peripheral, non-small cell lung cancer tumors.
Source: www.annalsthoracicsurgery.orgCategories: General Medicine News, Hem/OncsTweet-
Here is a link to the scientific article they reference: https://t.co/7uqwViCVZw
-
-
Mashup Score: 17
Before lung cancer resection, patients inquire about dyspnea and the potential need for supplemental oxygen. The objective of this study was to identify predictors of discharge with supplemental oxygen for patients undergoing lobectomy for lung cancer.
Source: www.annalsthoracicsurgery.orgCategories: General Medicine News, Hem/OncsTweet-
New data demonstrate 8% of patients undergoing lobectomy at STS reporting sites were discharged with supplemental oxygen from 2018-2021. At 30 days, slightly more than 3% remained on supplemental oxygen. 🫁 https://t.co/1nxH8tFhAE https://t.co/iKLeTrVD3m
-
-
Mashup Score: 5Expanding access to lung cancer screening - Bristol Myers Squibb - 1 month(s) ago
Discover how the BMS Foundation is breaking barriers to lung cancer screening and bringing life-saving access to underserved communities across the U.S.
Source: www.bms.comCategories: General Medicine News, Hem/OncsTweet-
Here is a message from an organization that has walked the walk on its commitment to reducing lung cancer mortality, including sponsoring the incredibly successful VA-PALS program and our new CAL-PALS program. 🌴 @bmsnews https://t.co/rvfeS3Z0VQ https://t.co/eDEO7N9xwj
-
-
Mashup Score: 5New Georgia law could make it easier for cancer patients to get access to personalized cancer care - 1 month(s) ago
Patty Watkins was diagnosed with stage 4 lung cancer in 2014. She says biomarker testing helped her doctors choose treatments most likely to work against her cancer.
Source: www.fox5atlanta.comCategories: General Medicine News, Hem/OncsTweet-
More recently, we tragically lost our beloved Patty Watkins, who only a few months earlier was pushing for legislation to ensure all lung cancer patients in Georgia have access to biomarker testing. 🫁https://t.co/vWiIoZ9Uy5 https://t.co/YAjnH54BT3
-
-
Mashup Score: 12Join Team Draft! Together we can Change The Face of Lung Cancer - 1 month(s) ago
Visit teamdraft.org and read 5 facts about lung cancer you may not know! Be sure to learn more about how you can join Team Draft and help Change the Face of Lung Cancer.
Source: www.teamdraft.orgCategories: General Medicine News, Hem/OncsTweet-
Next, there was the loss of Gina, who we miss more than words can say. 🫁 @HollenbeckGreg https://t.co/yhJFEBNIpD https://t.co/5VSY08Vk83
-
RT @G_S_Bhogal: Okay, here it is: the full story of my interactions with the alleged CEO shooter Luigi Mangione. https://t.co/FRC5tT8rVD